Valeo Pharma Inc. , a Canadian pharmaceutical company, provided comments on a recently issued newsletter by MDBriefCase entitled "Exploring Novel Therapeutic Approaches for Covid-19: Hesperidin vs Vitamin C".
Valeo Pharma has received approval for its Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug Administration (FDA) for Ethacrynate Sodium 50 mg.
Valeo Pharma Inc., a specialty pharmaceutical company dedicated to the commercialization of innovative prescription products, and Besins Healthcare, a global pharmaceutical company world leader in novel therapies for gynecology and andrology, today announ